The United States has reached a pivotal trade agreement with Switzerland and Liechtenstein that sets a maximum pharmaceutical tariff rate of 15%, a move expected to reshape trade dynamics in the global pharma sector. Announced today by officials from all three nations, the deal aims to foster greater market access, reduce costs, and enhance collaboration in pharmaceutical manufacturing and distribution. Industry observers view the agreement as a significant step towards strengthening transatlantic ties and supporting innovation in healthcare.
New US Trade Agreement Limits Pharma Tariffs for Switzerland and Liechtenstein to 15 Percent
The recent trade agreement between the United States and the Swiss Confederation, encompassing Liechtenstein as well, sets a maximum tariff cap of 15 percent on pharmaceutical products. This new cap aims to foster greater market access and competitiveness for pharmaceutical companies within these European nations, promoting smoother cross-border…
—-
Author : EURO-NEWS
Publish date : 2025-12-18 16:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
